Patent US4859681A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4859681A Expired / Lapsed US ⏱️ 0.0 years remaining

17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors

Assignee: Merck and Co Inc
•
Filing: 1987-12-03
•
Granted: 1989-08-22
•
Expires: 2007-12-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 17 beta -Acyl-4-aza-5 alpha -androst-1-en-3-ones of the formula: <IMAGE> I wherein R is selected from hydrogen, methyl and ethyl and R2 is a monovalent radical selected from straight carbons, or monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or 1 or more halo (Cl or Br) substituents, aralkyl selected from benzyl and phenethyl and heterocyclic selected from 2- or 4-pyridyl, 2-pyrrolyl, 2-furyl or thiophenyl; and R', R'' and R''' are each selected from hydrogen and methyl and pharmaceutical formulation of the above compounds are active as testosterone 5 alpha -reductase inhibitors and thus are useful topically for treatment of acne, seborrhea, female hirsutism, and systemically in treatment of benign prostatic hypertrophy.

Inventors

  • 👤 Gary H. Rasmusson
  • 👤 Glenn F. Reynolds

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 22:38
CPC Classifications
C; C07; C07C; C07C62/00; C07C62/30; C07C62/38; C07J; C07J73/00; C07J73/001; C07J73/005; C07C2603/00; C07C2603/02; C07C2603/04; C07C2603/06; C07C2603/10; C07C2603/12; C07C2603/16

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 36 words
A compound of the formula: ##STR8## wherein R is selected from hydrogen, methyl and ethyl and R 2 is branched chain alkyl of from 3-12 carbons, R', R", R'" are each selected from hydrogen and methyl.
Claim 2
Dependent Claim 36 words
A compound of the formula: ##STR8## wherein R is selected from hydrogen, methyl and ethyl and R 2 is branched chain alkyl of from 3-12 carbons, R', R", R'" are each selected from hydrogen and methyl.
Claim 3
Dependent Claim 28 words
A compound of claim 1 having the formula ##STR9## wherein R is hydrogen, methyl or ethyl and R 3 is branched chain alkyl of from 4-8 carbon atoms.
Claim 4
Dependent Claim 10 words
A compound of claim 1 wherein the compound is 22-methyl-4-aza-21-nor-5α-chol-1-ene-3,20-dione.
Claim 5
Dependent Claim 10 words
A compound of claim 1 wherein the compound is 4,22-dimethyl-4-aza-21-nor-5α-chol-1-ene-3,20-dione.
Claim 6
Dependent Claim 10 words
A compound of claim 1 wherein the compound is 23-methyl-4-aza-21-nor-5α-chol-1-ene-3,20-dione.
Claim 7
Dependent Claim 50 words
A method of treating the hyperandrogenic condition of acne vulgaris, seborrhea, female hirsutism, and benign prostatic hypertrophy comprising parenteral administration to a patient in need of such treatment of a therapeutically effective amount of a compound of formula: ##STR10## wherein R and R 2 are defined as in claim 1.
Claim 8
Dependent Claim 34 words
The method of claim 6 where there is employed a compound of the formula: ##STR11## wherein R is hydrogen, methyl or ethyl and R 2 is branched chain alkyl of from 4-8 carbon atoms.
Claim 9
Dependent Claim 60 words
A method of inhibiting testosterone 5α-reductase in a patient in need of such inhibiting treatment, comprising administration to such a patient of a therapeutically effective amount of a compound of the formula: ##STR12## wherein R and R 2 are defined as in claim 1, R' is hydrogen or methyl, R" is hydrogen or β-methyl, R"' is hydrogen, α-methyl or β-methyl.
Claim 10
Dependent Claim 36 words
The compound of claim 8 wherein there is employed a compound of the formula: ##STR13## wherein R is selected from hydrogen, methyl and ethyl and R 3 is branched chain alkyl of from 4-8 carbon atoms.
Claim 11
Dependent Claim 29 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of a compound of formula: ##STR14## wherein R and R 2 are defined as in claim 1.
Claim 12
Dependent Claim 34 words
The composition of claim 10 wherein there is employed a compound of the formula: ##STR15## wherein R is hydrogen, methyl or ethyl, and R 3 is branched chain alkyl of from 4-8 carbon atoms.

References Cited (Backward Citations)

US2227876A Cited
US3285918A Cited
US3239417A Cited
US3264301A Cited
FR1465544A Cited
CA970692A Cited
US4377584A Cited
EP0004949B1 Cited
US4220775A Cited
US4760071A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-08-21 1993-02-20 1993-08-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-08-21 1997-02-20 1997-08-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-08-21 2001-02-20 2001-08-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag